ClinicalTrials.gg
RecruitingNCT06850818EPR-HDUpdated Jun 11, 2026

Heidelberg Registry for Hip and Knee Joint Implants and Revisions

An observational study in Osteoarthritis and Arthroplasty, sponsored by University Hospital Heidelberg. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-11.

Sponsored by University Hospital Heidelberg · Observational

From the registry’s dates

  • Started Jan 2007; still recruiting 19 years 10 months later.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
10,000
Ages
18 Years and older
Sex
All
01

Study summary

The Endoprosthesis Registry Heidelberg (EPR-HD) is a clinical registry designed to systematically collect and analyze data from patients undergoing primary implantation or revision surgery of artificial hip and knee joints. The main objective of the registry is to evaluate long-term outcomes, complication rates, implant survival, and functional results associated with joint replacement procedures in patients with various hip and knee joint pathologies.

By gathering comprehensive clinical data, EPR-HD aims to improve the understanding of patient outcomes after endoprosthetic procedures, identify potential factors influencing implant success, and support evidence-based improvements in surgical techniques and patient care. The registry includes adult patients treated at Heidelberg University Hospital, with data collected at multiple time points during routine clinical follow-up. This registry will contribute to the optimization of joint replacement strategies and promote high-quality patient care.

Read the detailed description

The Endoprosthesis Registry Heidelberg (EPR-HD) is designed to provide comprehensive, long-term data on patients undergoing primary implantation or revision surgery of hip and knee endoprostheses. The registry aims to enhance the understanding of factors affecting the survival and functionality of joint implants, providing essential insights for optimizing surgical strategies and improving patient outcomes.

Hip and knee arthroplasty are among the most common orthopedic procedures worldwide, yet long-term data on implant performance and patient-specific risk factors remain limited. The EPR-HD registry addresses this knowledge gap by systematically collecting clinical data, including patient demographics, surgical details, implant characteristics, perioperative outcomes, and long-term follow-up results. Complication rates, reasons for revision, and functional outcomes such as mobility, pain levels, and quality of life will be assessed over time.

The registry includes adult patients treated at Heidelberg University Hospital who undergo either primary implantation or revision surgery of hip or knee joints due to various pathologies, including osteoarthritis, rheumatoid arthritis, and post-traumatic conditions. Data will be collected prospectively during routine clinical visits at standardized follow-up intervals (e.g., 1 year, 3 years and every 5 years postoperatively).

By evaluating real-world clinical outcomes, EPR-HD will contribute to identifying risk factors associated with implant failure and complications, supporting the development of evidence-based treatment protocols. The insights gained from this registry will promote high-quality care, optimize surgical decision-making, and improve the long-term success of joint replacement procedures in diverse patient populations

02

Conditions studied

  • Osteoarthritis
  • Arthroplasty

Browse trials for

Keywords

  • Endoprostheses
  • Arthroplasty
  • Joint Replacement
  • Osteoarthritis
  • Registry
  • Knee
  • Hip
03

In context

Osteoarthritis

2,974 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

This study's planned enrollment of 10,000 is above the median of 100 across 601 observational studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

University Hospital Heidelberg is the lead sponsor of 177 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients undergoing surgery at the Department of Orthopedic Surgery, Heidelberg University Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients undergoing hip or knee arthroplasty at our institution
  • All patients undergoing revision surgery following hip oder knee arthroplasty

Exclusion criteria

Exclusion Criteria:

  • Lack of prospective consent for study participation
  • Lack of capacity to provide
  • Minor status (underage)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
10,000 participants (estimated)
Target follow-up
20 Years
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Survival analysis with the endpoint revision for any reason

    Kaplan Meier Analysis

    Time frame: Preoperative, 1 year, 3 years, and every 5 years

Secondary outcomes

  1. Knee Society Score

    The Knee Society Score (KSS) provides a 0 to 100 score measuring function, pain, and range of motion in the knee before and after surgery. A score of 0 indicates the worst outcome, while a score of 100 indicates the best outcome.

    Time frame: preoperative, 1 year, 3 years and every 5 years

  2. Forgotten Joint Score

    The Forgotten Joint Score assesses how aware the patient is of their joint in everyday life. A score of 0 is the worst (always aware) while a score of 100 is the best (the patient is so comfortable, they forget that the joint was replaced).

    Time frame: preoperative, 1 year, 3 years and every 5 years

  3. Oxford Knee/Hip Score

    The Oxford Knee Score (OKS) provides a 0 to 48 score measuring function, pain, and range of motion in the knee before and after surgery. A score of 0 indicates the worst outcome, while a score of 48 indicates the best outcome

    Time frame: preoperative, 1 year, 3 years and every 5 years

  4. Harris Hip

    This survey assesses pain, deformity, and range of motion of the hip. A score of 0 indicates the worst outcome and 100 indicates the best.

    Time frame: preoperative, 1 year, 3 years and every 5 years

  5. Tegner Activity Scale

    The Tegner Activity Scale is a standardized scoring system used to assess a patient's level of physical activity and participation in sports or occupational tasks. The scale ranges from 0 to 10, where 0 indicates disability due to knee problems and 10 represents participation in competitive sports at the national or international elite level

    Time frame: preoperative, 1 year, 3 years and every 5 years

  6. The University of California, Los Angeles (UCLA) Activity Score

    The University of California, Los Angeles (UCLA) Activity Score is a validated scale used to assess the activity level of patients, particularly following joint replacement surgeries. The score ranges from 1 to 10, where 1 represents complete inactivity and dependence on others, while 10 indicates regular participation in impact sports.

    Time frame: preoperative, 1 year, 3 years and every 5 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2007 (actual). Primary completion is estimated for Dec 2035, 347 months after the start.

Of 146 non-industry observational studies under Osteoarthritis, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 97. This study's planned 347 months is above that.

Counting every sponsor, half of 228 studies reached it within 57 months; a quarter within 21 and three quarters within 141.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 22, 2025
First posted
Feb 27, 2025
StartActual
Jan 1, 2007
Primary completionEst.
Dec 2035
CompletionEst.
Dec 2035
Last update
Jun 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06850818
Responsible party
Mustafa Hariri (Principal Investigator, University Hospital Heidelberg) — Principal investigator
First posted
Feb 27, 2025
Start date
Jan 1, 2007
Primary completion
Dec 2035 (estimated)
Completion
Dec 2035 (estimated)
Last update
Jun 11, 2026

Study contacts

Mustafa Hariri, MD
Contact
mustafa.hariri@med.uni-heidelberg.de
004962215635652

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion